Clinical Study of ATTR-CM

NCT04935021 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Transthyroxine Amyloidosis Cardiomyopathy

Interventions

DRUG: ATTR-CM

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University